Literature DB >> 25215080

Effects of pituitary adenylate cyclase activating polypeptide on CD4(+)/CD8(+) T cell levels after traumatic brain injury in a rat model.

Rong Hua1, Shan-Shan Mao1, Yong-Mei Zhang1, Fu-Xing Chen1, Zhong-Hai Zhou1, Jun-Quan Liu1.   

Abstract

BACKGROUND: The effect of pituitary adenylate cyclase activating polypeptide (PACAP) during traumatic brain injury (TBI) and whether it can modulate secondary injury has not been reported previously. The present study evaluated the potential protective effects of ventricular infusion of PACAP in a rat model of TBI.
METHODS: Male Sprague Dawley rats were randomly divided into 3 treatment groups (n=6, each): sham-operated, vehicle (normal saline)+TBI, and PACAP+TBI. Normal saline or PACAP (1 μg/5 μL) was administered intracerebroventricularly 20 minutes before TBI. Right parietal cortical contusion was produced via a weight-dropping method. Brains were extracted 24 hours after trauma. Histological changes in brains were examined by HE staining. The numbers of CD4(+) and CD8(+) T cells in blood and the spleen were detected via flow cytometry.
RESULTS: In injured brain regions, edema, hemorrhage, inflammatory cell infiltration, and swollen and degenerated neurons were observed under a light microscope, and the neurons were disorderly arrayed in the hippocampi. Compared to the sham group, average CD4(+) CD8(-) lymphocyte counts in blood and the spleen were significantly decreased in rats that received TBI+vehicle, and CD4(-) CD8(+) were increased. In rats administered PACAP prior to TBI, damage was attenuated as evidenced by significantly increased CD4(+), and decreased CD8(+), T lymphocytes in blood and the spleen.
CONCLUSION: Pretreatment with PACAP may protect against TBI by influencing periphery T cellular immune function.

Entities:  

Keywords:  Blood; CD4+ T lymphocyte; CD8+ T lymphocyte; Flow cytometry; Pituitary adenylate cyclase activating polypeptide; Rat; Spleen; Traumatic brain injury

Year:  2012        PMID: 25215080      PMCID: PMC4129813          DOI: 10.5847/wjem.j.issn.1920-8642.2012.04.010

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  19 in total

Review 1.  Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents.

Authors:  Mario Delgado; Doina Ganea
Journal:  Brain Behav Immun       Date:  2008-06-14       Impact factor: 7.217

Review 2.  The neuropeptides VIP/PACAP and T cells: inhibitors or activators?

Authors:  Doina Ganea; Mario Delgado
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

3.  VIP and PACAP inhibit Fas ligand-mediated bystander lysis by CD4(+) T cells.

Authors:  M Delgado; D Ganea
Journal:  J Neuroimmunol       Date:  2001-01-01       Impact factor: 3.478

4.  Comparison of lactate, base excess, bicarbonate, and pH as predictors of mortality after severe trauma in rhesus macaques (Macaca mulatta).

Authors:  Theodore R Hobbs; Jean P O'Malley; Samone Khouangsathiene; Christopher J Dubay
Journal:  Comp Med       Date:  2010-06       Impact factor: 0.982

5.  Effect of Aerva lanata on cell-mediated immune responses and cytotoxic T-lymphocyte generation in normal and tumor-bearing mice.

Authors:  K S Siveen; Girija Kuttan
Journal:  J Immunotoxicol       Date:  2011-11-30       Impact factor: 3.000

6.  Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells.

Authors:  Hideki Kato; Atsushi Ito; Jun Kawanokuchi; Shijie Jin; Tetsuya Mizuno; Kosei Ojika; Ryuzou Ueda; Akio Suzumura
Journal:  Mult Scler       Date:  2004-12       Impact factor: 6.312

Review 7.  Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide.

Authors:  S Bourgault; D Vaudry; A Dejda; N D Doan; H Vaudry; A Fournier
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  Transduction of PACAP38 protects primary cortical neurons from neurotoxic injury.

Authors:  Alma Sanchez; Maurizo Chiriva-Internati; Paula Grammas
Journal:  Neurosci Lett       Date:  2008-10-14       Impact factor: 3.046

9.  Responses to cortical injury: I. Methodology and local effects of contusions in the rat.

Authors:  D M Feeney; M G Boyeson; R T Linn; H M Murray; W G Dail
Journal:  Brain Res       Date:  1981-04-27       Impact factor: 3.252

10.  Posttraumatic administration of pituitary adenylate cyclase activating polypeptide in central fluid percussion injury in rats.

Authors:  Erzsébet Kövesdi; Andrea Tamás; Dóra Reglodi; Orsolya Farkas; József Pál; Gábor Tóth; Péter Bukovics; Tamás Dóczi; András Büki
Journal:  Neurotox Res       Date:  2008-04       Impact factor: 3.978

View more
  5 in total

Review 1.  White matter damage after traumatic brain injury: A role for damage associated molecular patterns.

Authors:  Molly Braun; Kumar Vaibhav; Nancy M Saad; Sumbul Fatima; John R Vender; Babak Baban; Md Nasrul Hoda; Krishnan M Dhandapani
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-19       Impact factor: 5.187

Review 2.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

Review 3.  The Neuroprotective and Biomarker Potential of PACAP in Human Traumatic Brain Injury.

Authors:  Denes Toth; Andrea Tamas; Dora Reglodi
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

Review 4.  Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.

Authors:  Viktoria Denes; Peter Geck; Adrienn Mester; Robert Gabriel
Journal:  J Clin Med       Date:  2019-09-18       Impact factor: 4.241

Review 5.  Revisiting Traumatic Brain Injury: From Molecular Mechanisms to Therapeutic Interventions.

Authors:  Abbas Jarrahi; Molly Braun; Meenakshi Ahluwalia; Rohan V Gupta; Michael Wilson; Stephanie Munie; Pankaj Ahluwalia; John R Vender; Fernando L Vale; Krishnan M Dhandapani; Kumar Vaibhav
Journal:  Biomedicines       Date:  2020-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.